Novartis Oncology Controller Salaries in Baltimore, MD | Comparably
At Novartis Oncology, we are passionate about the discovery and development of innovative medicines. read more
EMPLOYEE
PARTICIPANTS
14
TOTAL
RATINGS
161

Novartis Oncology Controller Salaries in Baltimore, MD

The average Novartis Oncology Controller in Baltimore, MD earns an estimated $116,461 annually. Novartis Oncology's Controller compensation is $6,818 less than the US average for a Controller.

In Baltimore, MD, The Finance Department at Novartis Oncology earns $7,429 more on average than the Operations Department.

Last updated 3 years ago.

$47k
$71k
$95k
$118k
$180k
$240k
$300k
$116,461
Average Compensation
$116,461
avg. base

Controller Salaries at Novartis Oncology

In Baltimore, MD, Controllers earn $27,307 more than Financial Analysts, and $2,441 less than Accounting Managers.

Accounting Manager
$119k*
Financial Analyst
$89k*
Business Analyst
$89k*
Senior Accountant
$78k*
Accountant
$69k*
* estimated salary

Compensation at Novartis Oncology by Department

In Baltimore, MD, The Finance Department averages $7,429 more than the Operations Department, and $11,203 less than the Business Development Department

Business Development
$95,491 Avg. total comp.
+$11k
Finance
$84,288 Avg. total comp.
Operations
$76,859 Avg. total comp.
-$7k

Controller Compensation by Gender (All Companies)

The average female Controller at companies similar size to Novartis Oncology reported making $138,290, while the average male Controller at similar sized companies reported making $133,282.

Controller Compensation by Ethnicity (All Companies)

The average Asian or Pacific Islander Controller at companies similar size to Novartis Oncology reported making $132,409, while the average Caucasian Controller at similar sized companies reported making $129,306.

How Controllers at Novartis Oncology Rate Their Compensation

The majority of Controllers at Novartis Oncology believe they're not compensated fairly. 100% of Controllers at Novartis Oncology say they receive annual bonuses, and the vast majority (83%) are satisfied with their benefits. See more compensation ratings at Novartis Oncology

×
Rate your company